2-(4-Amino-Phenyl)-Pyrrolidine-1-Carboxylic Acid Tert-Butyl Ester

During the scale-up of a late-stage reductive amination step en route to an ATP-competitive anaplastic lymphoma kinase (ALK) inhibitor clinical candidate, 2-(4-amino-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester is first subjected to global acidolytic deprotection. A jacketed glass-lined reactor rated for −20 °C to 120 °C is charged with the carbamate and anhydrous 1,4-dioxane (water content < 50 ppm by coulometric Karl Fischer titration, Mettler Toledo C30S). Into this stirred suspension is metered a chilled solution of 4.0 M hydrogen chloride in 1,4-dioxane (3.5 eq HCl relative to Boc groups) at a rate maintaining internal temperature ≤ 5 °C. Off-gas vented through a caustic scrubber conveys isobutylene and CO₂ away from the batch. After 14 h of aging at 20–22 °C, the precipitated hydrochloride salt is isolated on a pressure Nutsche filter under nitrogen blanketing, washed with diethyl ether (peroxide-free, stabilized with 2 ppm BHT), and vacuum-dried at 40 °C to a loss on drying < 0.5 %. The dry salt is immediately reconstituted in anhydrous tetrahydrofuran (THF, inhibited with 250 ppm 2,6-di-tert-butyl-4-methylphenol) and treated with 1.05 eq of 5-chloro-6-((4-fluorophenyl)ethynyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbaldehyde. After stirring for 30 min to pre-form the Schiff base, sodium triacetoxyborohydride (STAB, 1.5 eq, particle size D₅₀ ≤ 100 µm) is added portion-wise at −5 °C to 0 °C. The slurry is aged for 5 h and quenched into vigorously agitated 8 wt% aqueous sodium bicarbonate. The biphasic mixture is stirred for 45 min (CO₂ evolution ceases), the organic phase is separated, and the aqueous layer is back-extracted with 2-methyltetrahydrofuran. The combined organics are washed with a 15 wt% NaCl solution, treated with activated carbon (Norit SX Plus, 2 wt% relative to theoretical product), and polish-filtered through a 0.45 µm polypropylene cartridge. Azeotropic distillation under reduced pressure (180 mbar, jacket 55 °C) removes residual water to < 200 ppm. The concentrate is diluted with n-heptane/ethyl acetate (4:1 v/v) and cooled linearly at −0.1 °C/min to −10 °C, yielding a crystalline freebase. Residual boron is scavenged by washing the wet cake with methanolic HCl (pH 2.5) and then heptane, delivering a penultimate intermediate with 99.3 area% purity by HPLC (Waters XBridge C18, 5 µm, 4.6×150 mm; 0.1% TFA in water/acetonitrile gradient, UV 254 nm). Residual 1,4-dioxane is controlled to < 380 ppm per ICH Q3C Class 2 Option 1, and boron to < 10 ppm per ICH Q3D oral PDE guidance by an in-process inductively coupled plasma mass spectrometry (ICP-MS) limit test. Downstream salt formation with methanesulfonic acid (1.02 eq) in acetone at 50 °C provides the target ALK inhibitor mesylate monohydrate in polymorphic Form I confirmed by XRPD (Rigaku MiniFlex, Cu Kα, scan 2–40 ° 2θ).

Why Pd₂(dba)₃/RuPhos Consistently Outperforms Pd(OAc)₂/P(t-Bu)₃ in Buchwald–Hartwig Amination of the Deprotected Pyrrolidine Aniline

When the Boc group of the protected pyrrolidine aniline is removed to liberate the free 4-(pyrrolidin-2-yl)aniline skeleton, the resulting primary aniline is sterically hindered by the ortho-substituted pyrrolidine ring but still nucleophilic enough to participate in C–N cross-couplings. Process development for a phosphodiesterase 10A (PDE10A) inhibitor program identified Pd₂(dba)₃ (tris(dibenzylideneacetone)dipalladium(0)) in combination with 2-dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl (RuPhos) as the sole catalyst-ligand system able to suppress competing β-hydride elimination and aryl–aryl homocoupling at manufacturing-relevant substrate concentrations. In a typical campaign, the deprotected amine hydrochloride (1.00 eq, 0.45 M in degassed 1,2-dimethoxyethane) is reacted with 2-bromo-5-fluoropyridine (1.22 eq), powdered anhydrous potassium phosphate tribasic (2.10 eq, prior drying at 150 °C/10 mbar for 48 h), Pd₂(dba)₃ (0.25 mol% dimer, equivalent to 0.50 mol% Pd), and RuPhos (1.00 mol%) under a purified argon atmosphere (residual O₂ < 10 ppm monitored by a Teledyne oxygen sensor). The batch is heated to 83 ± 2 °C for 8–10 h, at which point UPLC conversion of the limiting aniline exceeds 97.5%. The cooled reaction mass is diluted with 2-MeTHF, filtered through a Celite-545 pad to remove insoluble palladium black, and treated with a silica-bound dithiol metal scavenger (PhosphonicS MTCf, 5 wt% relative to theoretical product) for 6 h at 60 °C to lower residual Pd below 5 ppm. After concentration and crystallization from isopropyl acetate/n-heptane (1:3 v/v), the 5-fluoropyridinyl-pyrrolidine aniline intermediate is obtained with 99.1 wt% assay (HPLC, external standard) and 4.8 ppm residual palladium by ICP-MS—compliant with ICH Q3D Category 2B oral limits (PDE 10 µg/day). The isolated material is telescoped without further purification into a subsequent sulfonamide formation with cyclopropanesulfonyl chloride, ultimately giving the PDE10A inhibitor free base suitable for wet granulation with a lactose/microcrystalline cellulose filler matrix.

In the production of second-generation NS5A replication complex inhibitors that contain a bis-pyrrolidine diphenylacetylene dimer pharmacophore, the Boc-protected building block enables a regioselective Sonogashira alkynylation at the 4-amino position while maintaining the pyrrolidine nitrogen in a non-nucleophilic, deactivated state. The carbamate is dissolved in deoxygenated tetrahydrofuran/triethylamine (3:1 v/v, sparged with argon through a sintered frit for 90 min) and charged with 1-iodo-4-ethynylbenzene (1.05 eq), bis(triphenylphosphine)palladium(II) dichloride (0.4 mol%), and copper(I) iodide (0.8 mol%). The reaction proceeds at 22–25 °C with gentle jacket cooling to mitigate the mild exotherm; after 3.5 h HPLC indicates ≥ 96% conversion of the iodoalkyne. The catalyst poisons are precipitated by passing the solution through a short column of silica-supported thiol (SilicaMetS-DMT, 10 wt% relative to alkynylation substrate) and a layer of Florisil to remove copper residues below the 15 ppm oral PDE threshold of ICH Q3D. Following concentration, the crude alkynylated carbamate is crystallized from a ternary system of toluene/acetone/heptane (5:2:3) at −5 °C to remove trace triphenylphosphine oxide. The isolated intermediate then undergoes quantitative Boc removal using a trifluoroacetic acid/dichloromethane (1:1) cocktail containing 5% triisopropylsilane as a cation scavenger; the deprotected trifluoroacetate salt is partitioned directly into aqueous sodium hydroxide and ethyl acetate. After solvent exchange into dimethylformamide, the free amine is dimerized through sequential HATU-mediated couplings with methyloxycarbonyl-L-valine and a biphenyl dicarboxylic acid linker. The final dimeric NS5A inhibitor precursor is purified by preparative HPLC (Kromasil C8, 10 µm; acetonitrile/ammonium acetate buffer pH 4.5) and lyophilized. Residual THF is controlled to < 720 ppm per ICH Q3C Class 2 limits using a headspace GC-FID method (Agilent 7697A/7890B, DB-624 30 m × 0.32 mm × 1.8 µm). The overall sequence furnishes the NS5A dimer scaffold with 99.5% diastereomeric purity evaluated by chiral SFC (Chiralpak IA-3, CO₂/methanol gradient).

Dynamic Mechanical Analysis of a Latent Epoxy-Anhydride Thermoset Triggered by Thermally Labile Carbamate Decomposition

In single-component epoxy formulations for impregnation of high-voltage electric motor windings, the tert-butyl carbamate moiety of 2-(4-amino-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester functions as a built-in thermal triggering group, rendering the aromatic pyrrolidine amine dormant until the processing temperature exceeds the decomposition threshold of the urethane linkage. A typical formulation consists of a bisphenol-A diglycidyl ether liquid resin (EEW 184–190 g/eq, viscosity 11–14 Pa·s at 25 °C), methylhexahydrophthalic anhydride (MHHPA, 85 phr, ratio 0.85:1.0 epoxy-to-anhydride equivalents), and the Boc-protected pyrrolidine aniline as a latent accelerator/co-curing agent at levels from 0.5 to 3.0 phr. The pre-mixture exhibits a Brookfield viscosity (ASTM D2196-20, spindle 7, 20 rpm) of 860 mPa·s at 23 °C and exhibits no gelation upon storage at 25 °C for > 6 months when sealed from atmospheric moisture. Differential scanning calorimetry (DSC) on a TA Instruments Discovery 2500, sealed Tzero aluminum pan, 10 K/min from 30 °C to 280 °C, reveals a sharp exothermic event with onset temperature 138.2 °C and peak maximum at 165.7 °C, corresponding to tert-butyl cation release, decarboxylation, and concurrent nucleophilic attack of the liberated amine on the oxirane ring. The liberated isobutylene and CO₂ act as internal plasticizers during the early vitrification stage, a mechanism confirmed by thermogravimetric analysis–mass spectrometry (TGA-MS) showing m/z 56 and 44 fragments evolving between 130 °C and 175 °C. After an optimized cure schedule of 1 h at 120 °C (induction), 2 h at 150 °C (gelation and network expansion), and 1 h at 190 °C (full vitrification), the thermoset achieves a glass transition temperature (Tg) of 152.3 °C as the peak of the loss modulus curve measured by dynamic mechanical analysis (DMA, TA Instruments Q800, single cantilever, 1 Hz, 3 °C/min, specimen 60×12×3 mm) per ASTM D7028-07(2024). The crosslink density calculated from the rubbery plateau modulus (G′ at Tg+40 °C) reaches 1.82 × 10⁻³ mol/cm³, significantly higher than the 1.15 × 10⁻³ mol/cm³ obtained with the industry-standard latent hardener dicyandiamide in the same epoxy/anhydride backbone. Extraction testing (acetonitrile reflux, 16 h) followed by LC-MS/MS quantitation of free 2-(4-aminophenyl)pyrrolidine reveals 0.08 µg/dm² migration, well below the specific migration limit of 10 µg/dm² for non-listed primary aromatic amines under European Commission Regulation (EU) No 10/2011 (Annex II), enabling consideration for indirect food-contact applications. The cured network additionally meets the halogen-free criteria of IEC 61249-2-21:2003 (bromine < 900 ppm, chlorine < 900 ppm, combined < 1500 ppm) and RoHS Directive 2011/65/EU as confirmed by combustion ion chromatography (Metrohm 930 Combustion IC).

A telescoped deprotection-amidation sequence operated in a continuous flow platform demonstrates how the Boc-pyrrolidine aniline scaffold can be integrated into the supply chain of ryanodine receptor modulator diamide insecticides. A stainless-steel coil reactor (ID 1.0 mm, length 15 m, volume 11.8 mL) is fed with a pre-cooled (−10 °C) solution of 2-(4-amino-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester in dichloromethane (0.35 M) and a separate stream of trifluoroacetic acid (8.0 eq) at a combined residence time of 45 s. Quantitative conversion to the deprotected TFA salt is confirmed by inline FTIR monitoring (Mettler Toledo ReactIR 702L, DiComp probe, C=O shift from 1685 cm⁻¹ to 1645 cm⁻¹). The emergent stream is neutralized in-line with sodium hydroxide (4.0 M) in a micro-mixer chip and mixed with a dichloromethane solution of 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carbonyl chloride (1.02 eq). The amidation occurs within a residence coil maintained at 5 °C with a throughput of 4.2 g/h of the starting carbamate. The biphasic output is separated in a membrane phase separator (Zaiput SEP-10, PTFE membrane 1.0 µm); the organic phase is washed, dried over molecular sieves (3 Å), and concentrated under continuous vacuum distillation. Direct crystallization from methanol/water (3:1) yields the chlorantraniliprole-analogue penultimate amide with 98.7 wt% purity. Residual TFA is controlled to < 0.05 wt% by ion chromatography (Dionex ICS-6000), ensuring the intermediate meets the purity requirement for subsequent salt formation without deleterious impact on insecticidal activity. The entire telescoped sequence, from Boc removal to isolated crystalline amide, completes in under 8 minutes of total residence time, a reduction from the 22 h batch cycle typical for the equivalent step under Schotten-Baumann conditions. Regulatory registration under REACH requires documentation of the specific migration potential of any unreacted carbamate; headspace GC-MS screening at 0.01 ppm detection limit demonstrates that the finished diamide active ingredient contains no detectable levels of the Boc precursor.

What Limits the Optical Purity of the Desired (R)-Enantiomer During Diastereomeric Salt Resolution of the Racemic Pyrrolidine Aniline?

When the racemate of 2-(4-amino-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester is required to be separated into its component (R)- and (S)-atropisomers for incorporation into chirally pure pharmaceutical leads, the most scalable industrial approach remains diastereomeric salt resolution of the deprotected free amine, followed by re-installation of the Boc protecting group with strict enantiomeric fidelity. The racemic carbamate is first deprotected with HCl in isopropanol (5.0 M, 3.5 eq) at 35 °C until homogenous, then concentrated and basified to liberate the racemic 2-(4-aminophenyl)pyrrolidine. This free base is dissolved in methanol/water (10:1 v/v) at a concentration of 0.25 M and treated with 0.55 eq of (2S,3S)-2,3-di(benzoyloxy)succinic acid (L-DBTA) at 60 °C. Controlled cooling at −0.15 °C/min to 5 °C over 6 h precipitates the (R)-pyrrolidine•L-DBTA diastereomeric salt as fine needles. The isolated salt exhibits 96.5% ee of the (R)-amine by chiral HPLC (Chiralpak AD-H, 4.6×250 mm, hexane/ethanol/diethylamine 80:20:0.1, 0.8 mL/min, UV 254 nm). A single reslurry in acetonitrile/water (95:5) at 40 °C upgrades the enantiomeric excess to ≥ 99.8% ee. To re-protect the resolved amine without racemization, the salt is partitioned between saturated aqueous sodium bicarbonate and isopropyl acetate, and the free (R)-amine is treated with di-tert-butyl dicarbonate (Boc₂O, 1.08 eq) in THF at 0 °C to 5 °C for 3 h. Chiral SFC analysis of the reprotected (R)-2-(4-amino-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester confirms 99.9% ee and stereochemical integrity fully comparable to the enantiomer obtained by asymmetric hydrogenation. The process is governed by ICH Q7 guidelines for active pharmaceutical ingredient Good Manufacturing Practice; the mother liquor containing the (S)-enantiomer-enriched fraction is subjected to racemization with potassium tert-butoxide in DMSO at 80 °C and recycled, raising the overall process yield above 82% relative to the racemic starting material. Residual L-DBTA in the final product is quantified by charged aerosol detection (CAD) HPLC and kept below 0.05 wt%, compliant with the ICH Q3A unspecified individual impurity threshold for substances dosed at < 2 g/day.